Alkermes, Inc. (Nasdaq: ALKS) 11.8% LOWER; has received notification from Ortho-McNeil-Janssen Pharmaceuticals, Inc. and Janssen Pharmaceutica International, a division of Cilag International AG, that based on a portfolio review it has decided not to pursue further development of the four-week long-acting injectable formulation of risperidone.

Sigma Designs Inc. (Nasdaq: SIGM) 7.1% LOWER; reports Q2 EPS of $0.28, ex-items, in-line with the analyst estimate of $0.28. Revenue for the quarter was $51.3 million, versus the consensus of $51.48 million.

Jo-Ann Stores, Inc. (NYSE: JAS) 6.4% HIGHER; reports Q2 loss of $0.13, versus the analyst estimate of ($0.39). Revenue for the